--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Semaglutide App for GLP-1" developer_entity: "Kmish, Inc." bundle_id: "kmish.semaglutide" app_store_id: "6451262352" category: "Medical" primary_platform: "ios" primary_monetization: "Freemium" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "2026-03-25" report_date: "2026-08-23" last_verified: "2026-08-23T00:00:00.000Z" report_version: "1.1.9" total_reviews: 851 overall_rating: 4.7 sentiment: "Excited" sentiment_score: 65 confidence: "medium" confidence_score: 0.6 top_praise_theme: "The simple interface for tracking protein and water intake helps users manage their health goals effectively" top_complaint_theme: "Data loss and inability to view historical logs prevent users from tracking their long-term progress" review_sample_size: 38 total_review_count: 38 analyzed_review_count: 38 data_age_days: 83 momentum_velocity: "zombie" intelligence_version: 3 tags: ["medical", "freemium", "excited sentiment", "mobile app", "app review", "app analysis", "individuals", "prescribed", "glp-1"] canonical_url: "https://marlvel.ai/apps/semaglutide-app-for-glp-1" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Semaglutide App for GLP-1 Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Freemium - **Signal**: Rating 4.67 · Sentiment Excited - **Recent focus**: Data loss and inability to view historical logs prevent users from tracking their long-term progress (top complaint) · The simple interface for tracking protein and water intake helps users manage their health goals effectively (top praise) > **TL;DR:** Semaglutide App for GLP-1 is a medical app by Kmish, Inc., rated 4.67/5 by 851 users, with Excited user sentiment (65/100), available on iOS. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Semaglutide App for GLP-1 maintains Excited user sentiment (4.67/5 from 851 reviews), with users consistently praising the simple interface for tracking protein and water intake helps users manage their health goals effectively. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.67/5 (851 reviews) | | **User Mood** | Excited | | **Category** | Medical | | **Developer** | Kmish, Inc. | | **Pricing** | Freemium | | **Platforms** | iOS | | **Confidence** | Medium (0.6/1.0) | | **Data Age** | 83d | ## Metadata & Market Performance - **Publisher:** Kmish, Inc. - **Category:** Medical - **Target Audience:** Individuals prescribed GLP-1 medications like semaglutide or tirzepatide who require tracking tools for weight loss, protein intake, and insurance authorization documentation. - **Platforms:** iOS - **Version Reviewed:** 1.1.9 - **Report Date:** 2026-08-23 - **Signal Count:** 38 reviews analyzed - **Confidence:** Medium (0.6/1.0) - **App Store ID (iOS):** 6451262352 - **Bundle ID:** kmish.semaglutide - **Performance Trend:** Declining - **Data Window:** Analysis based on signals collected up to 2026-08-23 ## Executive Snapshot **What it is:** Semaglutide App for GLP-1 is a medical tracking tool for individuals on GLP-1 and GIP peptide therapies, offering injection, protein, and lifestyle logging on iOS. **Why users hire it:** The app removes the administrative friction of gathering health data for insurance prior authorization, a specific pain point for patients on expensive peptide therapies. ## App DNA (Features & Intent) - **[Differentiator] AI Nutrition Assistant:** Calculates meal plans and protein goals; premium-tier gate ($9.99/month) drives paid conversion. * *User Intent:* Users seek enhanced value through premium features. - **[Differentiator] Lifestyle Modification Log:** Documents health changes for insurance prior authorization; premium-tier gate ($9.99/month) provides B2B-style utility. * *User Intent:* Users seek enhanced value through premium features. - **[Standard] Injection and Refill Tracker:** Logs medication administration; retention loop reinforces daily usage. * *User Intent:* Users are motivated by consistent progression and daily incentives. ## Market Position {#market-position} Semaglutide App for GLP-1 operates in the medical category with a 4.67 rating across 851 total ratings. The lack of updates for five months signals a defensive posture rather than an aggressive pursuit of market share. ## Monetization Strategy - **Model:** Freemium - **Tiers:** Free tier: basic logging and telehealth access, Pro plan: $9.99/month for AI nutrition assistant, lifestyle logs, and reports - **Analysis:** The freemium model anchors on a $9.99/month subscription to gate high-utility AI features and insurance-ready documentation. ## 🟢 User Sentiment (Medium Confidence: 38 of 38 reviews analyzed) {#user-sentiment} - **Overall Rating:** 4.67/5 - **Platform Split:** iOS 4.7/5 (851 ratings) - **Overall Sentiment:** Excited ### Top Praises - **The simple interface for tracking protein and water intake helps users manage their health goals effectively** - **Integrated educational guides and books provide valuable support for users navigating their weight loss journey** - **The free access to core tracking features allows users to manage their health without subscription costs** ### Top Complaints (Impact Areas) - **Data loss and inability to view historical logs prevent users from tracking their long-term progress** ## SWOT Analysis {#swot} **Core Strengths:** - Lifestyle modification journal provides B2B-style utility for insurance prior authorization - Protein-focused tracking addresses specific side-effect concerns like muscle mass loss **Growth Levers:** - Implement manual nutritional data override to resolve barcode scanner inaccuracies - Add medication dosage history export to satisfy medical team documentation requests ## Recent Changes (v2 → v3) {#recent-changes} The app has transitioned into a maintenance-only state, with the five-month update gap now formally identified as a primary weakness and a driver of churn risk. Strategic focus has shifted toward mitigating barcode scanner inaccuracies via manual data overrides. **Overall trend**: Declining **Compared at**: 2026-08-23 ### High-impact changes - **[Shifted] Maintenance-only posture** (positioning) ### Medium-impact changes - **[Added] Update gap as weakness** (swot) - **[Added] Protein-focused tracking strength** (swot) - **[Added] Manual override opportunity** (swot) ## What's New - **Latest (v1.1.9, 5 months ago):** Addressed minor bugs to improve stability. ## App Momentum (Zombie) {#momentum} - Quiet 5 months, bug fixes only. - Last major release March 2026. > **Cadence:** 1 total versions · 0 majors in last 6 months · 151 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} Semaglutide App for GLP-1 is a market-leading medical app that is free with in-app purchases. With a 4.67/5 rating from 851 reviews, it delivers strong user satisfaction. > **Bottom Line:** Stabilizing the data persistence layer would address the primary churn risk driving negative sentiment. If the app cannot maintain a reliable logging habit, the niche utility of the insurance documentation will not be enough to retain users against more stable competitors. **Best for:** Individuals prescribed GLP-1 medications like semaglutide or tirzepatide who require tracking tools for weight loss, protein intake, and insurance authorization documentation. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Audit data persistence layer because historical log loss is a top-cited churn risk -> stabilize daily retention ### Outlook: Declining The GLP-1 tracking segment is consolidating around tools that offer high-accuracy clinical data, and Semaglutide App for GLP-1 is currently falling behind due to a lack of maintenance. The five-month update gap suggests the product is not a priority, which will likely accelerate churn as users seek more reliable alternatives for their insurance documentation needs. - 🔴 The five-month update gap signals a maintenance-only posture, which prevents the app from addressing critical data-loss bugs that erode user trust. - 🔴 Inaccurate barcode scanner data leads to user frustration, which compounds the churn pressure already present from technical instability. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.67/5 | | Total Reviews | 851 | | Sentiment | Excited (65/100) | | Confidence | Medium | | Pricing Model | Freemium | | Platforms | iOS | | Key Features | 3 analyzed | | Trend | Declining | | Outlook | Declining | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Semaglutide App for GLP-1** (this app) | 4.67/5 | Excited | Kmish, Inc. | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** Kmish, Inc. - **Website:** [https://semaglutideapp.io/Semaglutide-App.html](https://semaglutideapp.io/Semaglutide-App.html) ## Data Sources & Links - **App Store ID:** 6451262352 - **Dev Site:** [Official Website](https://semaglutideapp.io/Semaglutide-App.html) - **Sources:** Developer website content, App store metadata, User reviews. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating - [*1O Patient Portal*](https://marlvel.ai/apps/1o-patient-portal) (1st Optimal, LLC) · N/A Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.6/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 38 - **Data Sources:** user reviews, developer website, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 83 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/semaglutide-app-for-glp-1) Data licensed for AI Agent attribution under CC-BY-NC 4.0.